drug combinations
336 articles
Taking a Systems Biology Approach to Find a New Pancreatic Cancer Target
Dr. Andrea Califano is using systems biology and cell regulators to find new targets in the search for ways to stop pancreatic cancer cells.
Pancreatic Cancer and Drug Interactions: What You Need to Know
Pharmacist Trevor Christ emphasizes the importance of sharing your medication list with your medical team and pharmacist.
What Is a Clinical Trial?
A clinical trial is a type of research study that tests new drugs or drug combinations, procedures, or medical devices in patients with specific diseases or conditions. The goal of a clinical trial is to determine if a potential new treatment is safe and effective. Treatments that are tested in clinical trials have already been […]
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
Clinical Trial For OncoTreat Being Developed
Medical research falls into one of three buckets: basic, clinical, and translational. Basic research is all about the nuts and bolts, demystifying at a fundamental level what makes a lethal disease like pancreatic cancer tick. Clinical research is all about patients, and finding out through rigorously controlled trials whether certain new drugs or other approaches […]
Evaluating Different Immunotherapy Combinations
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.
Compassionate Use: An Option Beyond Standard of Care
Dr. Allyson Ocean explains how patients can access investigational drugs under the FDA’s compassionate use program.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients
Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.
Blood-Based Test Predicts What Drugs May Work Best
Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Testing Treatment Combinations to Make Surgery More Effective
Can losartan (a high blood pressure drug) and immunotherapy combined with standard chemotherapy and radiation be an effective combination against pancreatic cancer?
Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers
Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.